Patent details

EP1829545 Title: PROSTAGLANDIN F2 ALPHA DERIVATIVE CONTAINING PRODUCTS

Basic Information

Publication number:
EP1829545
PCT Application Number:
PCT/JP/2005/023704
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP058198748
PCT Publication Number:
WO/2006/068266
First applicant's nationality:
Translation Language:
EPO Publication Language:
Not available
English Title of Invention:
PROSTAGLANDIN F2 ALPHA DERIVATIVE CONTAINING PRODUCTS
French Title of Invention:
PRODUITS CONTENANT UN DERIVE DE PROSTAGLANDINE F2 ALPHA
German Title of Invention:
PROSTAGLANDIN F2 ALPHA DERIVAT ENTHALTENDE PRODUKTE
SPC Number:

Dates

Filing date:
26/12/2005
Grant date:
02/05/2012
EP Publication Date:
02/05/2012
PCT Publication Date:
29/06/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/09/2007
EP B1 Publication Date:
02/05/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/12/2012
Expiration date:
26/12/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/12/2005
 
 

Name:
SANTEN PHARMACEUTICAL CO. LTD.
Address:
9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka-shi, Osaka 533, Japan (JP)

Inventor

1

Name:
YAMADA Hiroshi, SANTEN PHARMACEUTICAL CO., LTD.
Address:
Japan (JP)

2

Name:
KIMURA Akio, SANTEN PHARMACEUTICAL CO., LTD.
Address:
Japan (JP)

3

Name:
KADO Takehiro, SANTEN PHARMACEUTICAL CO., LTD.
Address:
Japan (JP)

Priority

Priority Number:
2004374009
Priority Date:
24/12/2004
Priority Country:
Japan (JP)

Classification

Main IPC Class:
A61K 31/5575;
Filing date Document type Number of pages